Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 27.03 Billion DKK | 10.33% |
| 2023 | 24.5 Billion DKK | 8.51% |
| 2022 | 22.57 Billion DKK | 16.23% |
| 2021 | 19.42 Billion DKK | 4.76% |
| 2020 | 18.54 Billion DKK | 3.37% |
| 2019 | 17.93 Billion DKK | 9.06% |
| 2018 | 16.44 Billion DKK | 5.93% |
| 2017 | 15.52 Billion DKK | 5.77% |
| 2016 | 14.68 Billion DKK | 5.55% |
| 2015 | 13.9 Billion DKK | 11.92% |
| 2014 | 12.42 Billion DKK | 6.82% |
| 2013 | 11.63 Billion DKK | 5.55% |
| 2012 | 11.02 Billion DKK | 8.37% |
| 2011 | 10.17 Billion DKK | 6.66% |
| 2010 | 9.53 Billion DKK | 8.13% |
| 2009 | 8.82 Billion DKK | 4.22% |
| 2008 | 8.46 Billion DKK | 5.24% |
| 2007 | 8.04 Billion DKK | 19.87% |
| 2006 | 6.7 Billion DKK | 7.65% |
| 2005 | 6.23 Billion DKK | 2.63% |
| 2004 | 6.07 Billion DKK | 7.12% |
| 2003 | 5.66 Billion DKK | 0.8% |
| 2002 | 5.62 Billion DKK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6.6 Billion DKK | 6.1% |
| 2024 Q3 | 6.88 Billion DKK | 4.54% |
| 2024 Q2 | 6.58 Billion DKK | -0.3% |
| 2023 FY | 24.5 Billion DKK | 8.51% |
| 2023 Q2 | 6.06 Billion DKK | -0.72% |
| 2023 Q1 | 6.1 Billion DKK | 0.76% |
| 2023 Q4 | 6.22 Billion DKK | 1.93% |
| 2023 Q3 | 6.1 Billion DKK | 0.78% |
| 2022 Q1 | 5.16 Billion DKK | 1.35% |
| 2022 FY | 22.57 Billion DKK | 16.23% |
| 2022 Q4 | 6.05 Billion DKK | 3.59% |
| 2022 Q3 | 5.84 Billion DKK | 6.31% |
| 2022 Q2 | 5.5 Billion DKK | 6.44% |
| 2021 FY | 19.42 Billion DKK | 4.76% |
| 2021 Q1 | 4.73 Billion DKK | 3.22% |
| 2021 Q2 | 4.75 Billion DKK | 0.32% |
| 2021 Q3 | 4.83 Billion DKK | 1.73% |
| 2021 Q4 | 5.1 Billion DKK | 5.48% |
| 2020 Q4 | 4.59 Billion DKK | 3.87% |
| 2020 Q3 | 4.41 Billion DKK | -8.38% |
| 2020 Q1 | 4.71 Billion DKK | 2.04% |
| 2020 FY | 18.54 Billion DKK | 3.37% |
| 2020 Q2 | 4.82 Billion DKK | 2.36% |
| 2019 Q3 | 4.59 Billion DKK | 4.5% |
| 2019 FY | 17.93 Billion DKK | 9.06% |
| 2019 Q1 | 4.32 Billion DKK | 2.05% |
| 2019 Q2 | 4.4 Billion DKK | 1.85% |
| 2019 Q4 | 4.61 Billion DKK | 0.41% |
| 2018 FY | 16.44 Billion DKK | 5.93% |
| 2018 Q1 | 3.95 Billion DKK | -0.63% |
| 2018 Q4 | 4.23 Billion DKK | 0.21% |
| 2018 Q3 | 4.22 Billion DKK | 4.71% |
| 2018 Q2 | 4.03 Billion DKK | 2.02% |
| 2017 Q4 | 3.98 Billion DKK | 1.74% |
| 2017 Q3 | 3.91 Billion DKK | 0.8% |
| 2017 Q1 | 3.75 Billion DKK | 0.43% |
| 2017 FY | 15.52 Billion DKK | 5.77% |
| 2017 Q2 | 3.88 Billion DKK | 3.36% |
| 2016 FY | 14.68 Billion DKK | 5.55% |
| 2016 Q2 | 3.6 Billion DKK | -1.53% |
| 2016 Q3 | 3.68 Billion DKK | 2.39% |
| 2016 Q1 | 3.65 Billion DKK | 0.97% |
| 2016 Q4 | 3.73 Billion DKK | 1.44% |
| 2015 Q3 | 3.54 Billion DKK | 2.7% |
| 2015 FY | 13.9 Billion DKK | 11.92% |
| 2015 Q1 | 3.3 Billion DKK | 2.71% |
| 2015 Q2 | 3.44 Billion DKK | 4.42% |
| 2015 Q4 | 3.62 Billion DKK | 2.29% |
| 2014 Q1 | 3.06 Billion DKK | 3.13% |
| 2014 Q3 | 3.13 Billion DKK | 3.88% |
| 2014 FY | 12.42 Billion DKK | 6.82% |
| 2014 Q4 | 3.21 Billion DKK | 2.55% |
| 2014 Q2 | 3.01 Billion DKK | -1.5% |
| 2013 Q1 | 2.86 Billion DKK | 0.56% |
| 2013 FY | 11.63 Billion DKK | 5.55% |
| 2013 Q4 | 2.97 Billion DKK | 0.41% |
| 2013 Q3 | 2.95 Billion DKK | 4.08% |
| 2013 Q2 | 2.84 Billion DKK | -0.8% |
| 2012 Q3 | 2.82 Billion DKK | 5.05% |
| 2012 Q4 | 2.84 Billion DKK | 0.74% |
| 2012 Q2 | 2.69 Billion DKK | 1.43% |
| 2012 FY | 11.02 Billion DKK | 8.37% |
| 2012 Q1 | 2.65 Billion DKK | 3.23% |
| 2011 Q2 | 2.46 Billion DKK | -3.07% |
| 2011 Q1 | 2.54 Billion DKK | 0.95% |
| 2011 FY | 10.17 Billion DKK | 6.66% |
| 2011 Q3 | 2.59 Billion DKK | 5.44% |
| 2011 Q4 | 2.57 Billion DKK | -1.0% |
| 2010 Q1 | 2.29 Billion DKK | 1.5% |
| 2010 FY | 9.53 Billion DKK | 8.13% |
| 2010 Q4 | 2.51 Billion DKK | 2.65% |
| 2010 Q3 | 2.45 Billion DKK | 7.92% |
| 2010 Q2 | 2.27 Billion DKK | -1.05% |
| 2009 Q2 | 2.11 Billion DKK | -3.51% |
| 2009 Q1 | 2.19 Billion DKK | 0.0% |
| 2009 FY | 8.82 Billion DKK | 4.22% |
| 2009 Q4 | 2.26 Billion DKK | 0.85% |
| 2009 Q3 | 2.24 Billion DKK | 5.85% |
| 2008 FY | 8.46 Billion DKK | 5.24% |
| 2007 FY | 8.04 Billion DKK | 19.87% |
| 2006 FY | 6.7 Billion DKK | 7.65% |
| 2005 FY | 6.23 Billion DKK | 2.63% |
| 2004 FY | 6.07 Billion DKK | 7.12% |
| 2003 FY | 5.66 Billion DKK | 0.8% |
| 2002 FY | 5.62 Billion DKK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -846844.077% |
| Ansell Limited | 1.61 Billion USD | -1569.24% |
| Ansell Limited | 1.61 Billion USD | -1569.24% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -14538.705% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -20013968.343% |
| Psykey, Inc. | 419.29 Thousand USD | -6446373.757% |
| ConvaTec Group Plc | 2.19 Billion USD | -1131.988% |
| ConvaTec Group Plc | 2.14 Billion USD | -1161.669% |
| Encision Inc. | 6.58 Million USD | -410323.387% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -1481056.76% |
| LifePoint, Inc. | -18.5 Thousand USD | 146108208.108% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -396641.524% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -3501195.337% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -2740667.78% |
| Reflect Scientific, Inc. | 1.08 Million USD | -2502320.951% |
| SmileDirectClub, Inc. | 470.74 Million USD | -5641.987% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -1344.212% |
| SheerVision, Inc. | 3.49 Million USD | -772316.584% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -1949702.856% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -3627635.061% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -25919752.708% |